Pay in 4 interest-free payments of $6.43 Learn more
Ships within 48 hours · Estimated delivery Nov 7 - Nov 12
BACKGROUND: GLP-1 RAs are a class of several medicines used to improve blood sugar (glucose) control and reduce the risk of heart disease in patients with type 2 diabetes
Buyer Takeaway: Realistic expectations: meaningful weight loss is possible with GLP-1 medications for eligible patients who commit to the full program, including lifestyle support components
Understanding its prevalence helps set realistic expectations for those starting the treatment
Reduced bone mineral density is not associated with significantly reduced bone quality in men and women practicing long-term calorie restriction with adequate nutrition
Most patients reach their target maintenance dose within 16 to 20 weeks, depending on individual tolerance and weight loss goals
